Harbor Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Hold |
1,474
| – | – | 0.06% | 228 |
|
|
2025
Q1 | $715K | Sell |
1,474
-419
| -22% | -$203K | 0.07% | 198 |
|
|
2024
Q4 | $762K | Sell |
1,893
-315
| -14% | -$127K | 0.07% | 183 |
|
|
2024
Q3 | $1.03M | Sell |
2,208
-11
| -0.5% | -$5.12K | 0.1% | 158 |
|
|
2024
Q2 | $1.04M | Buy |
2,219
+1
| +0% | +$469 | 0.11% | 139 |
|
|
2024
Q1 | $927K | Hold |
2,218
| – | – | 0.1% | 161 |
|
|
2023
Q4 | $902K | Buy |
2,218
+1,314
| +145% | +$535K | 0.1% | 151 |
|
|
2023
Q3 | $314K | Buy |
904
+50
| +6% | +$17.4K | 0.04% | 255 |
|
|
2023
Q2 | $301K | Hold |
854
| – | – | 0.04% | 285 |
|
|
2023
Q1 | $269K | Sell |
854
-200
| -19% | -$63K | 0.04% | 298 |
|
|
2022
Q4 | $304K | Sell |
1,054
-110
| -9% | -$31.8K | 0.05% | 275 |
|
|
2022
Q3 | $337K | Hold |
1,164
| – | – | 0.06% | 248 |
|
|
2022
Q2 | $328K | Hold |
1,164
| – | – | 0.05% | 251 |
|
|
2022
Q1 | $304K | Buy |
1,164
+150
| +15% | +$39.2K | 0.04% | 286 |
|
|
2021
Q4 | $223K | Buy |
1,014
+796
| +365% | +$175K | 0.03% | 357 |
|
|
2021
Q3 | $40K | Sell |
218
-437
| -67% | -$80.2K | 0.01% | 800 |
|
|
2021
Q2 | $132K | Buy |
655
+218
| +50% | +$43.9K | 0.02% | 446 |
|
|
2021
Q1 | $94K | Buy |
437
+55
| +14% | +$11.8K | 0.01% | 499 |
|
|
2020
Q4 | $90K | Sell |
382
-73
| -16% | -$17.2K | 0.01% | 480 |
|
|
2020
Q3 | $124K | Sell |
455
-671
| -60% | -$183K | 0.02% | 340 |
|
|
2020
Q2 | $327K | Buy |
1,126
+762
| +209% | +$221K | 0.07% | 190 |
|
|
2020
Q1 | $87K | Buy |
364
+108
| +42% | +$25.8K | 0.02% | 333 |
|
|
2019
Q4 | $56K | Buy |
+256
| New | +$56K | 0.01% | 392 |
|